Global Vaccine Microarray Patches (VMAPs) Supply, Demand and Key Producers, 2026-2032
The global Vaccine Microarray Patches (VMAPs) market size is expected to reach $ 234 million by 2032, rising at a market growth of 30.1% CAGR during the forecast period (2026-2032).
In 2025, global sales of Vaccine Microarray Patches (VMAPs) reached approximately 16 million pcs, with an average market price of about USD 2.30 pc, an annual production capacity of roughly 2.15 million pcs, and an industry-average gross margin of approximately 40%.
Vaccine Microarray Patches (VMAPs) are integrated vaccine dosage forms and delivery systems comprising arrays of microscopic projections, needles or cone-shaped structures mounted on a patch substrate and designed to place vaccine antigens, adjuvants, nucleic-acid constructs or other immunologically active components into the epidermal or superficial dermal layers of the skin. Vaccine loading may be achieved through dry coating, incorporation into dissolvable or biodegradable polymers, detachable tips, reservoir-assisted delivery or other precision formulation and deposition techniques. A complete VMAP product may include the microarray, vaccine formulation, adhesive or backing layer, protective packaging and a manual or spring-assisted single-use applicator. Its critical manufacturing and performance attributes include projection geometry, mechanical strength, vaccine loading uniformity, insertion reliability, dissolution or release time, antigen stability, sterility, residual dose, application feedback and compatibility with scalable production. VMAPs are intended to provide rapid and reproducible cutaneous vaccination while reducing dependence on conventional needles and syringes, sharps disposal and highly trained vaccinators. Their principal prospective uses include routine childhood immunisation, supplementary immunisation campaigns, seasonal adult vaccination, outbreak response, pandemic preparedness and delivery in settings where cold-chain capacity, healthcare personnel or access to fixed vaccination sites is constrained.
Vaccine Microarray Patches (VMAPs) should be viewed as integrated vaccine?device combination products rather than as a simple extension of conventional transdermal patches or cosmetic microneedles. The relevant industry boundary includes vaccine-loaded arrays, formulation and loading processes, application devices, clinical or pilot manufacturing and directly associated contract development and manufacturing services. It does not extend to ordinary intradermal syringes, needle-free jet injectors, unmedicated microneedle devices or vaccine antigen suppliers that have no responsibility for the patch itself. The most advanced public-health use case remains measles?rubella vaccination. WHO pipeline assessments identify Micron Biomedical and Vaxxas as the two principal MR-MAP developers with human clinical programmes, while QuadMedicine has advanced a hepatitis B microneedle vaccine into human investigation and a broader group of companies is working on influenza, rotavirus, COVID-19, nucleic-acid and multivalent vaccine candidates. Consequently, the 2025 and 2026 market cannot be interpreted as a conventional commercial vaccine market measured by approved doses sold. Current economic activity is largely composed of sponsored development programmes, clinical-patch supply, formulation work, technology licensing, engineering batches and manufacturing scale-up. Under a strict approved-product sales definition, the market remains effectively pre-commercial; under the adopted industry-economic-activity definition, it is measurable but still small and highly dependent on project timing.
Demand is likely to emerge first where the operational burden of needle-and-syringe vaccination is greatest. Measles?rubella campaigns, hepatitis B birth-dose delivery, seasonal influenza, outbreak response and immunisation in remote or resource-constrained settings offer clearer early value propositions than immediate replacement of all routine injections. The commercial case will depend on more than immunogenicity. Procurers and regulators will evaluate total delivered cost, residual vaccine dose, application success, thermostability, packaging density, waste handling, user training and the ability to manufacture hundreds of millions of consistent units. From a technology perspective, solid-coated high-density arrays can provide very rapid delivery but require precise coating and reproducible application forces; dissolving patches eliminate residual sharps but face formulation, moisture and payload constraints; detachable-tip and programmed-release designs may enable prime?boost delivery from a single application but add manufacturing and regulatory complexity. The market?s medium-term growth therefore depends on regulatory de-risking and manufacturing performance rather than on scientific novelty alone. Gavi planning assumptions place initial MR-MAP licensure and WHO prequalification around 2030, making the second half of the forecast period the likely point at which commercial procurement could begin to contribute meaningfully. Before that transition, investment will remain concentrated in clinical validation, dedicated facilities, quality systems, applicator design and partnerships between vaccine owners and MAP manufacturers.
This report studies the global Vaccine Microarray Patches (VMAPs) production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Vaccine Microarray Patches (VMAPs) and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Vaccine Microarray Patches (VMAPs) that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Vaccine Microarray Patches (VMAPs) total production and demand, 2021-2032, (K Pcs)
Global Vaccine Microarray Patches (VMAPs) total production value, 2021-2032, (USD Million)
Global Vaccine Microarray Patches (VMAPs) production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Pcs), (based on production site)
Global Vaccine Microarray Patches (VMAPs) consumption by region & country, CAGR, 2021-2032 & (K Pcs)
U.S. VS China: Vaccine Microarray Patches (VMAPs) domestic production, consumption, key domestic manufacturers and share
Global Vaccine Microarray Patches (VMAPs) production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Pcs)
Global Vaccine Microarray Patches (VMAPs) production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Pcs)
Global Vaccine Microarray Patches (VMAPs) production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Pcs)
This report profiles key players in the global Vaccine Microarray Patches (VMAPs) market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Vaxxas Pty Ltd, Micron Biomedical, Inc., QuadMedicine, Inc., Inventprise, LLC, Kindeva Drug Delivery, LTS Lohmann Therapie-Systeme AG, RAPHAS Co., Ltd., WCC BIOMEDICAL CO., LTD., Gylden Pharma Limited, Shenzhen BioQingLam Biotechnology Co., Ltd., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Vaccine Microarray Patches (VMAPs) market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Pcs) and average price (US$/Pc) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Vaccine Microarray Patches (VMAPs) Market, By Region:
1. How big is the global Vaccine Microarray Patches (VMAPs) market?
2. What is the demand of the global Vaccine Microarray Patches (VMAPs) market?
3. What is the year over year growth of the global Vaccine Microarray Patches (VMAPs) market?
4. What is the production and production value of the global Vaccine Microarray Patches (VMAPs) market?
5. Who are the key producers in the global Vaccine Microarray Patches (VMAPs) market?
6. What are the growth factors driving the market demand?
In 2025, global sales of Vaccine Microarray Patches (VMAPs) reached approximately 16 million pcs, with an average market price of about USD 2.30 pc, an annual production capacity of roughly 2.15 million pcs, and an industry-average gross margin of approximately 40%.
Vaccine Microarray Patches (VMAPs) are integrated vaccine dosage forms and delivery systems comprising arrays of microscopic projections, needles or cone-shaped structures mounted on a patch substrate and designed to place vaccine antigens, adjuvants, nucleic-acid constructs or other immunologically active components into the epidermal or superficial dermal layers of the skin. Vaccine loading may be achieved through dry coating, incorporation into dissolvable or biodegradable polymers, detachable tips, reservoir-assisted delivery or other precision formulation and deposition techniques. A complete VMAP product may include the microarray, vaccine formulation, adhesive or backing layer, protective packaging and a manual or spring-assisted single-use applicator. Its critical manufacturing and performance attributes include projection geometry, mechanical strength, vaccine loading uniformity, insertion reliability, dissolution or release time, antigen stability, sterility, residual dose, application feedback and compatibility with scalable production. VMAPs are intended to provide rapid and reproducible cutaneous vaccination while reducing dependence on conventional needles and syringes, sharps disposal and highly trained vaccinators. Their principal prospective uses include routine childhood immunisation, supplementary immunisation campaigns, seasonal adult vaccination, outbreak response, pandemic preparedness and delivery in settings where cold-chain capacity, healthcare personnel or access to fixed vaccination sites is constrained.
Vaccine Microarray Patches (VMAPs) should be viewed as integrated vaccine?device combination products rather than as a simple extension of conventional transdermal patches or cosmetic microneedles. The relevant industry boundary includes vaccine-loaded arrays, formulation and loading processes, application devices, clinical or pilot manufacturing and directly associated contract development and manufacturing services. It does not extend to ordinary intradermal syringes, needle-free jet injectors, unmedicated microneedle devices or vaccine antigen suppliers that have no responsibility for the patch itself. The most advanced public-health use case remains measles?rubella vaccination. WHO pipeline assessments identify Micron Biomedical and Vaxxas as the two principal MR-MAP developers with human clinical programmes, while QuadMedicine has advanced a hepatitis B microneedle vaccine into human investigation and a broader group of companies is working on influenza, rotavirus, COVID-19, nucleic-acid and multivalent vaccine candidates. Consequently, the 2025 and 2026 market cannot be interpreted as a conventional commercial vaccine market measured by approved doses sold. Current economic activity is largely composed of sponsored development programmes, clinical-patch supply, formulation work, technology licensing, engineering batches and manufacturing scale-up. Under a strict approved-product sales definition, the market remains effectively pre-commercial; under the adopted industry-economic-activity definition, it is measurable but still small and highly dependent on project timing.
Demand is likely to emerge first where the operational burden of needle-and-syringe vaccination is greatest. Measles?rubella campaigns, hepatitis B birth-dose delivery, seasonal influenza, outbreak response and immunisation in remote or resource-constrained settings offer clearer early value propositions than immediate replacement of all routine injections. The commercial case will depend on more than immunogenicity. Procurers and regulators will evaluate total delivered cost, residual vaccine dose, application success, thermostability, packaging density, waste handling, user training and the ability to manufacture hundreds of millions of consistent units. From a technology perspective, solid-coated high-density arrays can provide very rapid delivery but require precise coating and reproducible application forces; dissolving patches eliminate residual sharps but face formulation, moisture and payload constraints; detachable-tip and programmed-release designs may enable prime?boost delivery from a single application but add manufacturing and regulatory complexity. The market?s medium-term growth therefore depends on regulatory de-risking and manufacturing performance rather than on scientific novelty alone. Gavi planning assumptions place initial MR-MAP licensure and WHO prequalification around 2030, making the second half of the forecast period the likely point at which commercial procurement could begin to contribute meaningfully. Before that transition, investment will remain concentrated in clinical validation, dedicated facilities, quality systems, applicator design and partnerships between vaccine owners and MAP manufacturers.
This report studies the global Vaccine Microarray Patches (VMAPs) production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Vaccine Microarray Patches (VMAPs) and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Vaccine Microarray Patches (VMAPs) that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Vaccine Microarray Patches (VMAPs) total production and demand, 2021-2032, (K Pcs)
Global Vaccine Microarray Patches (VMAPs) total production value, 2021-2032, (USD Million)
Global Vaccine Microarray Patches (VMAPs) production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Pcs), (based on production site)
Global Vaccine Microarray Patches (VMAPs) consumption by region & country, CAGR, 2021-2032 & (K Pcs)
U.S. VS China: Vaccine Microarray Patches (VMAPs) domestic production, consumption, key domestic manufacturers and share
Global Vaccine Microarray Patches (VMAPs) production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Pcs)
Global Vaccine Microarray Patches (VMAPs) production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Pcs)
Global Vaccine Microarray Patches (VMAPs) production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Pcs)
This report profiles key players in the global Vaccine Microarray Patches (VMAPs) market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Vaxxas Pty Ltd, Micron Biomedical, Inc., QuadMedicine, Inc., Inventprise, LLC, Kindeva Drug Delivery, LTS Lohmann Therapie-Systeme AG, RAPHAS Co., Ltd., WCC BIOMEDICAL CO., LTD., Gylden Pharma Limited, Shenzhen BioQingLam Biotechnology Co., Ltd., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Vaccine Microarray Patches (VMAPs) market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Pcs) and average price (US$/Pc) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Vaccine Microarray Patches (VMAPs) Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Dissolving
- Non-dissolving
- Hyaluronic Acid
- Taurine
- Triple-helical Collagen
- Patches
- Direct Topical
- Routine Childhood Immunization
- Adolescent / Pre-adolescent Prevention
- Travel / Endemic Exposure / Post-exposure
- Respiratory Vaccines with Recurring Demand
- Outbreak / Pandemic Preparedness
- Vaxxas Pty Ltd
- Micron Biomedical, Inc.
- QuadMedicine, Inc.
- Inventprise, LLC
- Kindeva Drug Delivery
- LTS Lohmann Therapie-Systeme AG
- RAPHAS Co., Ltd.
- WCC BIOMEDICAL CO., LTD.
- Gylden Pharma Limited
- Shenzhen BioQingLam Biotechnology Co., Ltd.
- CeraVx B.V.
- Verndari, Inc.
- MEDRx Co., Ltd.
- Advaccine Biopharmaceuticals Suzhou Co., Ltd.
- Youwe (Zhuhai) Biotechnology Co., Ltd.
- CosMED Pharmaceutical Co., Ltd.
- SingleTimeMicroneedles, Inc.
1. How big is the global Vaccine Microarray Patches (VMAPs) market?
2. What is the demand of the global Vaccine Microarray Patches (VMAPs) market?
3. What is the year over year growth of the global Vaccine Microarray Patches (VMAPs) market?
4. What is the production and production value of the global Vaccine Microarray Patches (VMAPs) market?
5. Who are the key producers in the global Vaccine Microarray Patches (VMAPs) market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Vaccine Microarray Patches (VMAPs) Introduction
1.2 World Vaccine Microarray Patches (VMAPs) Supply & Forecast
1.2.1 World Vaccine Microarray Patches (VMAPs) Production Value (2021 & 2025 & 2032)
1.2.2 World Vaccine Microarray Patches (VMAPs) Production (2021-2032)
1.2.3 World Vaccine Microarray Patches (VMAPs) Pricing Trends (2021-2032)
1.3 World Vaccine Microarray Patches (VMAPs) Production by Region (Based on Production Site)
1.3.1 World Vaccine Microarray Patches (VMAPs) Production Value by Region (2021-2032)
1.3.2 World Vaccine Microarray Patches (VMAPs) Production by Region (2021-2032)
1.3.3 World Vaccine Microarray Patches (VMAPs) Average Price by Region (2021-2032)
1.3.4 North America Vaccine Microarray Patches (VMAPs) Production (2021-2032)
1.3.5 Europe Vaccine Microarray Patches (VMAPs) Production (2021-2032)
1.3.6 China Vaccine Microarray Patches (VMAPs) Production (2021-2032)
1.3.7 Japan Vaccine Microarray Patches (VMAPs) Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Vaccine Microarray Patches (VMAPs) Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Vaccine Microarray Patches (VMAPs) Major Market Trends
2 DEMAND SUMMARY
2.1 World Vaccine Microarray Patches (VMAPs) Demand (2021-2032)
2.2 World Vaccine Microarray Patches (VMAPs) Consumption by Region
2.2.1 World Vaccine Microarray Patches (VMAPs) Consumption by Region (2021-2026)
2.2.2 World Vaccine Microarray Patches (VMAPs) Consumption Forecast by Region (2027-2032)
2.3 United States Vaccine Microarray Patches (VMAPs) Consumption (2021-2032)
2.4 China Vaccine Microarray Patches (VMAPs) Consumption (2021-2032)
2.5 Europe Vaccine Microarray Patches (VMAPs) Consumption (2021-2032)
2.6 Japan Vaccine Microarray Patches (VMAPs) Consumption (2021-2032)
2.7 South Korea Vaccine Microarray Patches (VMAPs) Consumption (2021-2032)
2.8 ASEAN Vaccine Microarray Patches (VMAPs) Consumption (2021-2032)
2.9 India Vaccine Microarray Patches (VMAPs) Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Vaccine Microarray Patches (VMAPs) Production Value by Manufacturer (2021-2026)
3.2 World Vaccine Microarray Patches (VMAPs) Production by Manufacturer (2021-2026)
3.3 World Vaccine Microarray Patches (VMAPs) Average Price by Manufacturer (2021-2026)
3.4 Vaccine Microarray Patches (VMAPs) Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Vaccine Microarray Patches (VMAPs) Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Vaccine Microarray Patches (VMAPs) in 2025
3.5.3 Global Concentration Ratios (CR8) for Vaccine Microarray Patches (VMAPs) in 2025
3.6 Vaccine Microarray Patches (VMAPs) Market: Overall Company Footprint Analysis
3.6.1 Vaccine Microarray Patches (VMAPs) Market: Region Footprint
3.6.2 Vaccine Microarray Patches (VMAPs) Market: Company Product Type Footprint
3.6.3 Vaccine Microarray Patches (VMAPs) Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Vaccine Microarray Patches (VMAPs) Production Value Comparison
4.1.1 United States VS China: Vaccine Microarray Patches (VMAPs) Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Vaccine Microarray Patches (VMAPs) Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Vaccine Microarray Patches (VMAPs) Production Comparison
4.2.1 United States VS China: Vaccine Microarray Patches (VMAPs) Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Vaccine Microarray Patches (VMAPs) Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Vaccine Microarray Patches (VMAPs) Consumption Comparison
4.3.1 United States VS China: Vaccine Microarray Patches (VMAPs) Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Vaccine Microarray Patches (VMAPs) Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Vaccine Microarray Patches (VMAPs) Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Vaccine Microarray Patches (VMAPs) Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Vaccine Microarray Patches (VMAPs) Production Value (2021-2026)
4.4.3 United States Based Manufacturers Vaccine Microarray Patches (VMAPs) Production (2021-2026)
4.5 China Based Vaccine Microarray Patches (VMAPs) Manufacturers and Market Share
4.5.1 China Based Vaccine Microarray Patches (VMAPs) Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Vaccine Microarray Patches (VMAPs) Production Value (2021-2026)
4.5.3 China Based Manufacturers Vaccine Microarray Patches (VMAPs) Production (2021-2026)
4.6 Rest of World Based Vaccine Microarray Patches (VMAPs) Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Vaccine Microarray Patches (VMAPs) Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Vaccine Microarray Patches (VMAPs) Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Vaccine Microarray Patches (VMAPs) Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Vaccine Microarray Patches (VMAPs) Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Dissolving
5.2.2 Non-dissolving
5.3 Market Segment by Type
5.3.1 World Vaccine Microarray Patches (VMAPs) Production by Type (2021-2032)
5.3.2 World Vaccine Microarray Patches (VMAPs) Production Value by Type (2021-2032)
5.3.3 World Vaccine Microarray Patches (VMAPs) Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY MICRONEEDLE MATERIAL
6.1 World Vaccine Microarray Patches (VMAPs) Market Size Overview by Microneedle Material: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Microneedle Material
6.2.1 Hyaluronic Acid
6.2.2 Taurine
6.2.3 Triple-helical Collagen
6.3 Market Segment by Microneedle Material
6.3.1 World Vaccine Microarray Patches (VMAPs) Production by Microneedle Material (2021-2032)
6.3.2 World Vaccine Microarray Patches (VMAPs) Production Value by Microneedle Material (2021-2032)
6.3.3 World Vaccine Microarray Patches (VMAPs) Average Price by Microneedle Material (2021-2032)
7 MARKET ANALYSIS BY FORM OF USE
7.1 World Vaccine Microarray Patches (VMAPs) Market Size Overview by Form of Use: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Form of Use
7.2.1 Patches
7.2.2 Direct Topical
7.3 Market Segment by Form of Use
7.3.1 World Vaccine Microarray Patches (VMAPs) Production by Form of Use (2021-2032)
7.3.2 World Vaccine Microarray Patches (VMAPs) Production Value by Form of Use (2021-2032)
7.3.3 World Vaccine Microarray Patches (VMAPs) Average Price by Form of Use (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Vaccine Microarray Patches (VMAPs) Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Routine Childhood Immunization
8.2.2 Adolescent / Pre-adolescent Prevention
8.2.3 Travel / Endemic Exposure / Post-exposure
8.2.4 Respiratory Vaccines with Recurring Demand
8.2.5 Outbreak / Pandemic Preparedness
8.3 Market Segment by Application
8.3.1 World Vaccine Microarray Patches (VMAPs) Production by Application (2021-2032)
8.3.2 World Vaccine Microarray Patches (VMAPs) Production Value by Application (2021-2032)
8.3.3 World Vaccine Microarray Patches (VMAPs) Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 Vaxxas Pty Ltd
9.1.1 Vaxxas Pty Ltd Details
9.1.2 Vaxxas Pty Ltd Major Business
9.1.3 Vaxxas Pty Ltd Vaccine Microarray Patches (VMAPs) Product and Services
9.1.4 Vaxxas Pty Ltd Vaccine Microarray Patches (VMAPs) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 Vaxxas Pty Ltd Recent Developments/Updates
9.1.6 Vaxxas Pty Ltd Competitive Strengths & Weaknesses
9.2 Micron Biomedical, Inc.
9.2.1 Micron Biomedical, Inc. Details
9.2.2 Micron Biomedical, Inc. Major Business
9.2.3 Micron Biomedical, Inc. Vaccine Microarray Patches (VMAPs) Product and Services
9.2.4 Micron Biomedical, Inc. Vaccine Microarray Patches (VMAPs) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 Micron Biomedical, Inc. Recent Developments/Updates
9.2.6 Micron Biomedical, Inc. Competitive Strengths & Weaknesses
9.3 QuadMedicine, Inc.
9.3.1 QuadMedicine, Inc. Details
9.3.2 QuadMedicine, Inc. Major Business
9.3.3 QuadMedicine, Inc. Vaccine Microarray Patches (VMAPs) Product and Services
9.3.4 QuadMedicine, Inc. Vaccine Microarray Patches (VMAPs) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 QuadMedicine, Inc. Recent Developments/Updates
9.3.6 QuadMedicine, Inc. Competitive Strengths & Weaknesses
9.4 Inventprise, LLC
9.4.1 Inventprise, LLC Details
9.4.2 Inventprise, LLC Major Business
9.4.3 Inventprise, LLC Vaccine Microarray Patches (VMAPs) Product and Services
9.4.4 Inventprise, LLC Vaccine Microarray Patches (VMAPs) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.4.5 Inventprise, LLC Recent Developments/Updates
9.4.6 Inventprise, LLC Competitive Strengths & Weaknesses
9.5 Kindeva Drug Delivery
9.5.1 Kindeva Drug Delivery Details
9.5.2 Kindeva Drug Delivery Major Business
9.5.3 Kindeva Drug Delivery Vaccine Microarray Patches (VMAPs) Product and Services
9.5.4 Kindeva Drug Delivery Vaccine Microarray Patches (VMAPs) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.5.5 Kindeva Drug Delivery Recent Developments/Updates
9.5.6 Kindeva Drug Delivery Competitive Strengths & Weaknesses
9.6 LTS Lohmann Therapie-Systeme AG
9.6.1 LTS Lohmann Therapie-Systeme AG Details
9.6.2 LTS Lohmann Therapie-Systeme AG Major Business
9.6.3 LTS Lohmann Therapie-Systeme AG Vaccine Microarray Patches (VMAPs) Product and Services
9.6.4 LTS Lohmann Therapie-Systeme AG Vaccine Microarray Patches (VMAPs) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.6.5 LTS Lohmann Therapie-Systeme AG Recent Developments/Updates
9.6.6 LTS Lohmann Therapie-Systeme AG Competitive Strengths & Weaknesses
9.7 RAPHAS Co., Ltd.
9.7.1 RAPHAS Co., Ltd. Details
9.7.2 RAPHAS Co., Ltd. Major Business
9.7.3 RAPHAS Co., Ltd. Vaccine Microarray Patches (VMAPs) Product and Services
9.7.4 RAPHAS Co., Ltd. Vaccine Microarray Patches (VMAPs) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.7.5 RAPHAS Co., Ltd. Recent Developments/Updates
9.7.6 RAPHAS Co., Ltd. Competitive Strengths & Weaknesses
9.8 WCC BIOMEDICAL CO., LTD.
9.8.1 WCC BIOMEDICAL CO., LTD. Details
9.8.2 WCC BIOMEDICAL CO., LTD. Major Business
9.8.3 WCC BIOMEDICAL CO., LTD. Vaccine Microarray Patches (VMAPs) Product and Services
9.8.4 WCC BIOMEDICAL CO., LTD. Vaccine Microarray Patches (VMAPs) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.8.5 WCC BIOMEDICAL CO., LTD. Recent Developments/Updates
9.8.6 WCC BIOMEDICAL CO., LTD. Competitive Strengths & Weaknesses
9.9 Gylden Pharma Limited
9.9.1 Gylden Pharma Limited Details
9.9.2 Gylden Pharma Limited Major Business
9.9.3 Gylden Pharma Limited Vaccine Microarray Patches (VMAPs) Product and Services
9.9.4 Gylden Pharma Limited Vaccine Microarray Patches (VMAPs) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.9.5 Gylden Pharma Limited Recent Developments/Updates
9.9.6 Gylden Pharma Limited Competitive Strengths & Weaknesses
9.10 Shenzhen BioQingLam Biotechnology Co., Ltd.
9.10.1 Shenzhen BioQingLam Biotechnology Co., Ltd. Details
9.10.2 Shenzhen BioQingLam Biotechnology Co., Ltd. Major Business
9.10.3 Shenzhen BioQingLam Biotechnology Co., Ltd. Vaccine Microarray Patches (VMAPs) Product and Services
9.10.4 Shenzhen BioQingLam Biotechnology Co., Ltd. Vaccine Microarray Patches (VMAPs) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.10.5 Shenzhen BioQingLam Biotechnology Co., Ltd. Recent Developments/Updates
9.10.6 Shenzhen BioQingLam Biotechnology Co., Ltd. Competitive Strengths & Weaknesses
9.11 CeraVx B.V.
9.11.1 CeraVx B.V. Details
9.11.2 CeraVx B.V. Major Business
9.11.3 CeraVx B.V. Vaccine Microarray Patches (VMAPs) Product and Services
9.11.4 CeraVx B.V. Vaccine Microarray Patches (VMAPs) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.11.5 CeraVx B.V. Recent Developments/Updates
9.11.6 CeraVx B.V. Competitive Strengths & Weaknesses
9.12 Verndari, Inc.
9.12.1 Verndari, Inc. Details
9.12.2 Verndari, Inc. Major Business
9.12.3 Verndari, Inc. Vaccine Microarray Patches (VMAPs) Product and Services
9.12.4 Verndari, Inc. Vaccine Microarray Patches (VMAPs) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.12.5 Verndari, Inc. Recent Developments/Updates
9.12.6 Verndari, Inc. Competitive Strengths & Weaknesses
9.13 MEDRx Co., Ltd.
9.13.1 MEDRx Co., Ltd. Details
9.13.2 MEDRx Co., Ltd. Major Business
9.13.3 MEDRx Co., Ltd. Vaccine Microarray Patches (VMAPs) Product and Services
9.13.4 MEDRx Co., Ltd. Vaccine Microarray Patches (VMAPs) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.13.5 MEDRx Co., Ltd. Recent Developments/Updates
9.13.6 MEDRx Co., Ltd. Competitive Strengths & Weaknesses
9.14 Advaccine Biopharmaceuticals Suzhou Co., Ltd.
9.14.1 Advaccine Biopharmaceuticals Suzhou Co., Ltd. Details
9.14.2 Advaccine Biopharmaceuticals Suzhou Co., Ltd. Major Business
9.14.3 Advaccine Biopharmaceuticals Suzhou Co., Ltd. Vaccine Microarray Patches (VMAPs) Product and Services
9.14.4 Advaccine Biopharmaceuticals Suzhou Co., Ltd. Vaccine Microarray Patches (VMAPs) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.14.5 Advaccine Biopharmaceuticals Suzhou Co., Ltd. Recent Developments/Updates
9.14.6 Advaccine Biopharmaceuticals Suzhou Co., Ltd. Competitive Strengths & Weaknesses
9.15 Youwe (Zhuhai) Biotechnology Co., Ltd.
9.15.1 Youwe (Zhuhai) Biotechnology Co., Ltd. Details
9.15.2 Youwe (Zhuhai) Biotechnology Co., Ltd. Major Business
9.15.3 Youwe (Zhuhai) Biotechnology Co., Ltd. Vaccine Microarray Patches (VMAPs) Product and Services
9.15.4 Youwe (Zhuhai) Biotechnology Co., Ltd. Vaccine Microarray Patches (VMAPs) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.15.5 Youwe (Zhuhai) Biotechnology Co., Ltd. Recent Developments/Updates
9.15.6 Youwe (Zhuhai) Biotechnology Co., Ltd. Competitive Strengths & Weaknesses
9.16 CosMED Pharmaceutical Co., Ltd.
9.16.1 CosMED Pharmaceutical Co., Ltd. Details
9.16.2 CosMED Pharmaceutical Co., Ltd. Major Business
9.16.3 CosMED Pharmaceutical Co., Ltd. Vaccine Microarray Patches (VMAPs) Product and Services
9.16.4 CosMED Pharmaceutical Co., Ltd. Vaccine Microarray Patches (VMAPs) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.16.5 CosMED Pharmaceutical Co., Ltd. Recent Developments/Updates
9.16.6 CosMED Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
9.17 SingleTimeMicroneedles, Inc.
9.17.1 SingleTimeMicroneedles, Inc. Details
9.17.2 SingleTimeMicroneedles, Inc. Major Business
9.17.3 SingleTimeMicroneedles, Inc. Vaccine Microarray Patches (VMAPs) Product and Services
9.17.4 SingleTimeMicroneedles, Inc. Vaccine Microarray Patches (VMAPs) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.17.5 SingleTimeMicroneedles, Inc. Recent Developments/Updates
9.17.6 SingleTimeMicroneedles, Inc. Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Vaccine Microarray Patches (VMAPs) Industry Chain
10.2 Vaccine Microarray Patches (VMAPs) Upstream Analysis
10.2.1 Vaccine Microarray Patches (VMAPs) Core Raw Materials
10.2.2 Main Manufacturers of Vaccine Microarray Patches (VMAPs) Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 Vaccine Microarray Patches (VMAPs) Production Mode
10.6 Vaccine Microarray Patches (VMAPs) Procurement Model
10.7 Vaccine Microarray Patches (VMAPs) Industry Sales Model and Sales Channels
10.7.1 Vaccine Microarray Patches (VMAPs) Sales Model
10.7.2 Vaccine Microarray Patches (VMAPs) Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Vaccine Microarray Patches (VMAPs) Introduction
1.2 World Vaccine Microarray Patches (VMAPs) Supply & Forecast
1.2.1 World Vaccine Microarray Patches (VMAPs) Production Value (2021 & 2025 & 2032)
1.2.2 World Vaccine Microarray Patches (VMAPs) Production (2021-2032)
1.2.3 World Vaccine Microarray Patches (VMAPs) Pricing Trends (2021-2032)
1.3 World Vaccine Microarray Patches (VMAPs) Production by Region (Based on Production Site)
1.3.1 World Vaccine Microarray Patches (VMAPs) Production Value by Region (2021-2032)
1.3.2 World Vaccine Microarray Patches (VMAPs) Production by Region (2021-2032)
1.3.3 World Vaccine Microarray Patches (VMAPs) Average Price by Region (2021-2032)
1.3.4 North America Vaccine Microarray Patches (VMAPs) Production (2021-2032)
1.3.5 Europe Vaccine Microarray Patches (VMAPs) Production (2021-2032)
1.3.6 China Vaccine Microarray Patches (VMAPs) Production (2021-2032)
1.3.7 Japan Vaccine Microarray Patches (VMAPs) Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Vaccine Microarray Patches (VMAPs) Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Vaccine Microarray Patches (VMAPs) Major Market Trends
2 DEMAND SUMMARY
2.1 World Vaccine Microarray Patches (VMAPs) Demand (2021-2032)
2.2 World Vaccine Microarray Patches (VMAPs) Consumption by Region
2.2.1 World Vaccine Microarray Patches (VMAPs) Consumption by Region (2021-2026)
2.2.2 World Vaccine Microarray Patches (VMAPs) Consumption Forecast by Region (2027-2032)
2.3 United States Vaccine Microarray Patches (VMAPs) Consumption (2021-2032)
2.4 China Vaccine Microarray Patches (VMAPs) Consumption (2021-2032)
2.5 Europe Vaccine Microarray Patches (VMAPs) Consumption (2021-2032)
2.6 Japan Vaccine Microarray Patches (VMAPs) Consumption (2021-2032)
2.7 South Korea Vaccine Microarray Patches (VMAPs) Consumption (2021-2032)
2.8 ASEAN Vaccine Microarray Patches (VMAPs) Consumption (2021-2032)
2.9 India Vaccine Microarray Patches (VMAPs) Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Vaccine Microarray Patches (VMAPs) Production Value by Manufacturer (2021-2026)
3.2 World Vaccine Microarray Patches (VMAPs) Production by Manufacturer (2021-2026)
3.3 World Vaccine Microarray Patches (VMAPs) Average Price by Manufacturer (2021-2026)
3.4 Vaccine Microarray Patches (VMAPs) Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Vaccine Microarray Patches (VMAPs) Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Vaccine Microarray Patches (VMAPs) in 2025
3.5.3 Global Concentration Ratios (CR8) for Vaccine Microarray Patches (VMAPs) in 2025
3.6 Vaccine Microarray Patches (VMAPs) Market: Overall Company Footprint Analysis
3.6.1 Vaccine Microarray Patches (VMAPs) Market: Region Footprint
3.6.2 Vaccine Microarray Patches (VMAPs) Market: Company Product Type Footprint
3.6.3 Vaccine Microarray Patches (VMAPs) Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Vaccine Microarray Patches (VMAPs) Production Value Comparison
4.1.1 United States VS China: Vaccine Microarray Patches (VMAPs) Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Vaccine Microarray Patches (VMAPs) Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Vaccine Microarray Patches (VMAPs) Production Comparison
4.2.1 United States VS China: Vaccine Microarray Patches (VMAPs) Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Vaccine Microarray Patches (VMAPs) Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Vaccine Microarray Patches (VMAPs) Consumption Comparison
4.3.1 United States VS China: Vaccine Microarray Patches (VMAPs) Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Vaccine Microarray Patches (VMAPs) Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Vaccine Microarray Patches (VMAPs) Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Vaccine Microarray Patches (VMAPs) Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Vaccine Microarray Patches (VMAPs) Production Value (2021-2026)
4.4.3 United States Based Manufacturers Vaccine Microarray Patches (VMAPs) Production (2021-2026)
4.5 China Based Vaccine Microarray Patches (VMAPs) Manufacturers and Market Share
4.5.1 China Based Vaccine Microarray Patches (VMAPs) Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Vaccine Microarray Patches (VMAPs) Production Value (2021-2026)
4.5.3 China Based Manufacturers Vaccine Microarray Patches (VMAPs) Production (2021-2026)
4.6 Rest of World Based Vaccine Microarray Patches (VMAPs) Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Vaccine Microarray Patches (VMAPs) Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Vaccine Microarray Patches (VMAPs) Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Vaccine Microarray Patches (VMAPs) Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Vaccine Microarray Patches (VMAPs) Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Dissolving
5.2.2 Non-dissolving
5.3 Market Segment by Type
5.3.1 World Vaccine Microarray Patches (VMAPs) Production by Type (2021-2032)
5.3.2 World Vaccine Microarray Patches (VMAPs) Production Value by Type (2021-2032)
5.3.3 World Vaccine Microarray Patches (VMAPs) Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY MICRONEEDLE MATERIAL
6.1 World Vaccine Microarray Patches (VMAPs) Market Size Overview by Microneedle Material: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Microneedle Material
6.2.1 Hyaluronic Acid
6.2.2 Taurine
6.2.3 Triple-helical Collagen
6.3 Market Segment by Microneedle Material
6.3.1 World Vaccine Microarray Patches (VMAPs) Production by Microneedle Material (2021-2032)
6.3.2 World Vaccine Microarray Patches (VMAPs) Production Value by Microneedle Material (2021-2032)
6.3.3 World Vaccine Microarray Patches (VMAPs) Average Price by Microneedle Material (2021-2032)
7 MARKET ANALYSIS BY FORM OF USE
7.1 World Vaccine Microarray Patches (VMAPs) Market Size Overview by Form of Use: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Form of Use
7.2.1 Patches
7.2.2 Direct Topical
7.3 Market Segment by Form of Use
7.3.1 World Vaccine Microarray Patches (VMAPs) Production by Form of Use (2021-2032)
7.3.2 World Vaccine Microarray Patches (VMAPs) Production Value by Form of Use (2021-2032)
7.3.3 World Vaccine Microarray Patches (VMAPs) Average Price by Form of Use (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Vaccine Microarray Patches (VMAPs) Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Routine Childhood Immunization
8.2.2 Adolescent / Pre-adolescent Prevention
8.2.3 Travel / Endemic Exposure / Post-exposure
8.2.4 Respiratory Vaccines with Recurring Demand
8.2.5 Outbreak / Pandemic Preparedness
8.3 Market Segment by Application
8.3.1 World Vaccine Microarray Patches (VMAPs) Production by Application (2021-2032)
8.3.2 World Vaccine Microarray Patches (VMAPs) Production Value by Application (2021-2032)
8.3.3 World Vaccine Microarray Patches (VMAPs) Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 Vaxxas Pty Ltd
9.1.1 Vaxxas Pty Ltd Details
9.1.2 Vaxxas Pty Ltd Major Business
9.1.3 Vaxxas Pty Ltd Vaccine Microarray Patches (VMAPs) Product and Services
9.1.4 Vaxxas Pty Ltd Vaccine Microarray Patches (VMAPs) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 Vaxxas Pty Ltd Recent Developments/Updates
9.1.6 Vaxxas Pty Ltd Competitive Strengths & Weaknesses
9.2 Micron Biomedical, Inc.
9.2.1 Micron Biomedical, Inc. Details
9.2.2 Micron Biomedical, Inc. Major Business
9.2.3 Micron Biomedical, Inc. Vaccine Microarray Patches (VMAPs) Product and Services
9.2.4 Micron Biomedical, Inc. Vaccine Microarray Patches (VMAPs) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 Micron Biomedical, Inc. Recent Developments/Updates
9.2.6 Micron Biomedical, Inc. Competitive Strengths & Weaknesses
9.3 QuadMedicine, Inc.
9.3.1 QuadMedicine, Inc. Details
9.3.2 QuadMedicine, Inc. Major Business
9.3.3 QuadMedicine, Inc. Vaccine Microarray Patches (VMAPs) Product and Services
9.3.4 QuadMedicine, Inc. Vaccine Microarray Patches (VMAPs) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 QuadMedicine, Inc. Recent Developments/Updates
9.3.6 QuadMedicine, Inc. Competitive Strengths & Weaknesses
9.4 Inventprise, LLC
9.4.1 Inventprise, LLC Details
9.4.2 Inventprise, LLC Major Business
9.4.3 Inventprise, LLC Vaccine Microarray Patches (VMAPs) Product and Services
9.4.4 Inventprise, LLC Vaccine Microarray Patches (VMAPs) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.4.5 Inventprise, LLC Recent Developments/Updates
9.4.6 Inventprise, LLC Competitive Strengths & Weaknesses
9.5 Kindeva Drug Delivery
9.5.1 Kindeva Drug Delivery Details
9.5.2 Kindeva Drug Delivery Major Business
9.5.3 Kindeva Drug Delivery Vaccine Microarray Patches (VMAPs) Product and Services
9.5.4 Kindeva Drug Delivery Vaccine Microarray Patches (VMAPs) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.5.5 Kindeva Drug Delivery Recent Developments/Updates
9.5.6 Kindeva Drug Delivery Competitive Strengths & Weaknesses
9.6 LTS Lohmann Therapie-Systeme AG
9.6.1 LTS Lohmann Therapie-Systeme AG Details
9.6.2 LTS Lohmann Therapie-Systeme AG Major Business
9.6.3 LTS Lohmann Therapie-Systeme AG Vaccine Microarray Patches (VMAPs) Product and Services
9.6.4 LTS Lohmann Therapie-Systeme AG Vaccine Microarray Patches (VMAPs) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.6.5 LTS Lohmann Therapie-Systeme AG Recent Developments/Updates
9.6.6 LTS Lohmann Therapie-Systeme AG Competitive Strengths & Weaknesses
9.7 RAPHAS Co., Ltd.
9.7.1 RAPHAS Co., Ltd. Details
9.7.2 RAPHAS Co., Ltd. Major Business
9.7.3 RAPHAS Co., Ltd. Vaccine Microarray Patches (VMAPs) Product and Services
9.7.4 RAPHAS Co., Ltd. Vaccine Microarray Patches (VMAPs) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.7.5 RAPHAS Co., Ltd. Recent Developments/Updates
9.7.6 RAPHAS Co., Ltd. Competitive Strengths & Weaknesses
9.8 WCC BIOMEDICAL CO., LTD.
9.8.1 WCC BIOMEDICAL CO., LTD. Details
9.8.2 WCC BIOMEDICAL CO., LTD. Major Business
9.8.3 WCC BIOMEDICAL CO., LTD. Vaccine Microarray Patches (VMAPs) Product and Services
9.8.4 WCC BIOMEDICAL CO., LTD. Vaccine Microarray Patches (VMAPs) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.8.5 WCC BIOMEDICAL CO., LTD. Recent Developments/Updates
9.8.6 WCC BIOMEDICAL CO., LTD. Competitive Strengths & Weaknesses
9.9 Gylden Pharma Limited
9.9.1 Gylden Pharma Limited Details
9.9.2 Gylden Pharma Limited Major Business
9.9.3 Gylden Pharma Limited Vaccine Microarray Patches (VMAPs) Product and Services
9.9.4 Gylden Pharma Limited Vaccine Microarray Patches (VMAPs) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.9.5 Gylden Pharma Limited Recent Developments/Updates
9.9.6 Gylden Pharma Limited Competitive Strengths & Weaknesses
9.10 Shenzhen BioQingLam Biotechnology Co., Ltd.
9.10.1 Shenzhen BioQingLam Biotechnology Co., Ltd. Details
9.10.2 Shenzhen BioQingLam Biotechnology Co., Ltd. Major Business
9.10.3 Shenzhen BioQingLam Biotechnology Co., Ltd. Vaccine Microarray Patches (VMAPs) Product and Services
9.10.4 Shenzhen BioQingLam Biotechnology Co., Ltd. Vaccine Microarray Patches (VMAPs) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.10.5 Shenzhen BioQingLam Biotechnology Co., Ltd. Recent Developments/Updates
9.10.6 Shenzhen BioQingLam Biotechnology Co., Ltd. Competitive Strengths & Weaknesses
9.11 CeraVx B.V.
9.11.1 CeraVx B.V. Details
9.11.2 CeraVx B.V. Major Business
9.11.3 CeraVx B.V. Vaccine Microarray Patches (VMAPs) Product and Services
9.11.4 CeraVx B.V. Vaccine Microarray Patches (VMAPs) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.11.5 CeraVx B.V. Recent Developments/Updates
9.11.6 CeraVx B.V. Competitive Strengths & Weaknesses
9.12 Verndari, Inc.
9.12.1 Verndari, Inc. Details
9.12.2 Verndari, Inc. Major Business
9.12.3 Verndari, Inc. Vaccine Microarray Patches (VMAPs) Product and Services
9.12.4 Verndari, Inc. Vaccine Microarray Patches (VMAPs) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.12.5 Verndari, Inc. Recent Developments/Updates
9.12.6 Verndari, Inc. Competitive Strengths & Weaknesses
9.13 MEDRx Co., Ltd.
9.13.1 MEDRx Co., Ltd. Details
9.13.2 MEDRx Co., Ltd. Major Business
9.13.3 MEDRx Co., Ltd. Vaccine Microarray Patches (VMAPs) Product and Services
9.13.4 MEDRx Co., Ltd. Vaccine Microarray Patches (VMAPs) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.13.5 MEDRx Co., Ltd. Recent Developments/Updates
9.13.6 MEDRx Co., Ltd. Competitive Strengths & Weaknesses
9.14 Advaccine Biopharmaceuticals Suzhou Co., Ltd.
9.14.1 Advaccine Biopharmaceuticals Suzhou Co., Ltd. Details
9.14.2 Advaccine Biopharmaceuticals Suzhou Co., Ltd. Major Business
9.14.3 Advaccine Biopharmaceuticals Suzhou Co., Ltd. Vaccine Microarray Patches (VMAPs) Product and Services
9.14.4 Advaccine Biopharmaceuticals Suzhou Co., Ltd. Vaccine Microarray Patches (VMAPs) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.14.5 Advaccine Biopharmaceuticals Suzhou Co., Ltd. Recent Developments/Updates
9.14.6 Advaccine Biopharmaceuticals Suzhou Co., Ltd. Competitive Strengths & Weaknesses
9.15 Youwe (Zhuhai) Biotechnology Co., Ltd.
9.15.1 Youwe (Zhuhai) Biotechnology Co., Ltd. Details
9.15.2 Youwe (Zhuhai) Biotechnology Co., Ltd. Major Business
9.15.3 Youwe (Zhuhai) Biotechnology Co., Ltd. Vaccine Microarray Patches (VMAPs) Product and Services
9.15.4 Youwe (Zhuhai) Biotechnology Co., Ltd. Vaccine Microarray Patches (VMAPs) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.15.5 Youwe (Zhuhai) Biotechnology Co., Ltd. Recent Developments/Updates
9.15.6 Youwe (Zhuhai) Biotechnology Co., Ltd. Competitive Strengths & Weaknesses
9.16 CosMED Pharmaceutical Co., Ltd.
9.16.1 CosMED Pharmaceutical Co., Ltd. Details
9.16.2 CosMED Pharmaceutical Co., Ltd. Major Business
9.16.3 CosMED Pharmaceutical Co., Ltd. Vaccine Microarray Patches (VMAPs) Product and Services
9.16.4 CosMED Pharmaceutical Co., Ltd. Vaccine Microarray Patches (VMAPs) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.16.5 CosMED Pharmaceutical Co., Ltd. Recent Developments/Updates
9.16.6 CosMED Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
9.17 SingleTimeMicroneedles, Inc.
9.17.1 SingleTimeMicroneedles, Inc. Details
9.17.2 SingleTimeMicroneedles, Inc. Major Business
9.17.3 SingleTimeMicroneedles, Inc. Vaccine Microarray Patches (VMAPs) Product and Services
9.17.4 SingleTimeMicroneedles, Inc. Vaccine Microarray Patches (VMAPs) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.17.5 SingleTimeMicroneedles, Inc. Recent Developments/Updates
9.17.6 SingleTimeMicroneedles, Inc. Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Vaccine Microarray Patches (VMAPs) Industry Chain
10.2 Vaccine Microarray Patches (VMAPs) Upstream Analysis
10.2.1 Vaccine Microarray Patches (VMAPs) Core Raw Materials
10.2.2 Main Manufacturers of Vaccine Microarray Patches (VMAPs) Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 Vaccine Microarray Patches (VMAPs) Production Mode
10.6 Vaccine Microarray Patches (VMAPs) Procurement Model
10.7 Vaccine Microarray Patches (VMAPs) Industry Sales Model and Sales Channels
10.7.1 Vaccine Microarray Patches (VMAPs) Sales Model
10.7.2 Vaccine Microarray Patches (VMAPs) Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Vaccine Microarray Patches (VMAPs) Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Vaccine Microarray Patches (VMAPs) Production Value by Region (2021-2026) & (USD Million)
Table 3. World Vaccine Microarray Patches (VMAPs) Production Value by Region (2027-2032) & (USD Million)
Table 4. World Vaccine Microarray Patches (VMAPs) Production Value Market Share by Region (2021-2026)
Table 5. World Vaccine Microarray Patches (VMAPs) Production Value Market Share by Region (2027-2032)
Table 6. World Vaccine Microarray Patches (VMAPs) Production by Region (2021-2026) & (K Pcs)
Table 7. World Vaccine Microarray Patches (VMAPs) Production by Region (2027-2032) & (K Pcs)
Table 8. World Vaccine Microarray Patches (VMAPs) Production Market Share by Region (2021-2026)
Table 9. World Vaccine Microarray Patches (VMAPs) Production Market Share by Region (2027-2032)
Table 10. World Vaccine Microarray Patches (VMAPs) Average Price by Region (2021-2026) & (US$/Pc)
Table 11. World Vaccine Microarray Patches (VMAPs) Average Price by Region (2027-2032) & (US$/Pc)
Table 12. Vaccine Microarray Patches (VMAPs) Major Market Trends
Table 13. World Vaccine Microarray Patches (VMAPs) Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Pcs)
Table 14. World Vaccine Microarray Patches (VMAPs) Consumption by Region (2021-2026) & (K Pcs)
Table 15. World Vaccine Microarray Patches (VMAPs) Consumption Forecast by Region (2027-2032) & (K Pcs)
Table 16. World Vaccine Microarray Patches (VMAPs) Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Vaccine Microarray Patches (VMAPs) Producers in 2025
Table 18. World Vaccine Microarray Patches (VMAPs) Production by Manufacturer (2021-2026) & (K Pcs)
Table 19. Production Market Share of Key Vaccine Microarray Patches (VMAPs) Producers in 2025
Table 20. World Vaccine Microarray Patches (VMAPs) Average Price by Manufacturer (2021-2026) & (US$/Pc)
Table 21. Global Vaccine Microarray Patches (VMAPs) Company Evaluation Quadrant
Table 22. World Vaccine Microarray Patches (VMAPs) Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Vaccine Microarray Patches (VMAPs) Production Site of Key Manufacturer
Table 24. Vaccine Microarray Patches (VMAPs) Market: Company Product Type Footprint
Table 25. Vaccine Microarray Patches (VMAPs) Market: Company Product Application Footprint
Table 26. Vaccine Microarray Patches (VMAPs) Competitive Factors
Table 27. Vaccine Microarray Patches (VMAPs) New Entrant and Capacity Expansion Plans
Table 28. Vaccine Microarray Patches (VMAPs) Mergers & Acquisitions Activity
Table 29. United States VS China Vaccine Microarray Patches (VMAPs) Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Vaccine Microarray Patches (VMAPs) Production Comparison, (2021 & 2025 & 2032) & (K Pcs)
Table 31. United States VS China Vaccine Microarray Patches (VMAPs) Consumption Comparison, (2021 & 2025 & 2032) & (K Pcs)
Table 32. United States Based Vaccine Microarray Patches (VMAPs) Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Vaccine Microarray Patches (VMAPs) Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Vaccine Microarray Patches (VMAPs) Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Vaccine Microarray Patches (VMAPs) Production (2021-2026) & (K Pcs)
Table 36. United States Based Manufacturers Vaccine Microarray Patches (VMAPs) Production Market Share (2021-2026)
Table 37. China Based Vaccine Microarray Patches (VMAPs) Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Vaccine Microarray Patches (VMAPs) Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Vaccine Microarray Patches (VMAPs) Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Vaccine Microarray Patches (VMAPs) Production, (2021-2026) & (K Pcs)
Table 41. China Based Manufacturers Vaccine Microarray Patches (VMAPs) Production Market Share (2021-2026)
Table 42. Rest of World Based Vaccine Microarray Patches (VMAPs) Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Vaccine Microarray Patches (VMAPs) Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Vaccine Microarray Patches (VMAPs) Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Vaccine Microarray Patches (VMAPs) Production, (2021-2026) & (K Pcs)
Table 46. Rest of World Based Manufacturers Vaccine Microarray Patches (VMAPs) Production Market Share (2021-2026)
Table 47. World Vaccine Microarray Patches (VMAPs) Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Vaccine Microarray Patches (VMAPs) Production by Type (2021-2026) & (K Pcs)
Table 49. World Vaccine Microarray Patches (VMAPs) Production by Type (2027-2032) & (K Pcs)
Table 50. World Vaccine Microarray Patches (VMAPs) Production Value by Type (2021-2026) & (USD Million)
Table 51. World Vaccine Microarray Patches (VMAPs) Production Value by Type (2027-2032) & (USD Million)
Table 52. World Vaccine Microarray Patches (VMAPs) Average Price by Type (2021-2026) & (US$/Pc)
Table 53. World Vaccine Microarray Patches (VMAPs) Average Price by Type (2027-2032) & (US$/Pc)
Table 54. World Vaccine Microarray Patches (VMAPs) Production Value by Microneedle Material, (USD Million), 2021 & 2025 & 2032
Table 55. World Vaccine Microarray Patches (VMAPs) Production by Microneedle Material (2021-2026) & (K Pcs)
Table 56. World Vaccine Microarray Patches (VMAPs) Production by Microneedle Material (2027-2032) & (K Pcs)
Table 57. World Vaccine Microarray Patches (VMAPs) Production Value by Microneedle Material (2021-2026) & (USD Million)
Table 58. World Vaccine Microarray Patches (VMAPs) Production Value by Microneedle Material (2027-2032) & (USD Million)
Table 59. World Vaccine Microarray Patches (VMAPs) Average Price by Microneedle Material (2021-2026) & (US$/Pc)
Table 60. World Vaccine Microarray Patches (VMAPs) Average Price by Microneedle Material (2027-2032) & (US$/Pc)
Table 61. World Vaccine Microarray Patches (VMAPs) Production Value by Form of Use, (USD Million), 2021 & 2025 & 2032
Table 62. World Vaccine Microarray Patches (VMAPs) Production by Form of Use (2021-2026) & (K Pcs)
Table 63. World Vaccine Microarray Patches (VMAPs) Production by Form of Use (2027-2032) & (K Pcs)
Table 64. World Vaccine Microarray Patches (VMAPs) Production Value by Form of Use (2021-2026) & (USD Million)
Table 65. World Vaccine Microarray Patches (VMAPs) Production Value by Form of Use (2027-2032) & (USD Million)
Table 66. World Vaccine Microarray Patches (VMAPs) Average Price by Form of Use (2021-2026) & (US$/Pc)
Table 67. World Vaccine Microarray Patches (VMAPs) Average Price by Form of Use (2027-2032) & (US$/Pc)
Table 68. World Vaccine Microarray Patches (VMAPs) Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World Vaccine Microarray Patches (VMAPs) Production by Application (2021-2026) & (K Pcs)
Table 70. World Vaccine Microarray Patches (VMAPs) Production by Application (2027-2032) & (K Pcs)
Table 71. World Vaccine Microarray Patches (VMAPs) Production Value by Application (2021-2026) & (USD Million)
Table 72. World Vaccine Microarray Patches (VMAPs) Production Value by Application (2027-2032) & (USD Million)
Table 73. World Vaccine Microarray Patches (VMAPs) Average Price by Application (2021-2026) & (US$/Pc)
Table 74. World Vaccine Microarray Patches (VMAPs) Average Price by Application (2027-2032) & (US$/Pc)
Table 75. Vaxxas Pty Ltd Basic Information, Manufacturing Base and Competitors
Table 76. Vaxxas Pty Ltd Major Business
Table 77. Vaxxas Pty Ltd Vaccine Microarray Patches (VMAPs) Product and Services
Table 78. Vaxxas Pty Ltd Vaccine Microarray Patches (VMAPs) Production (K Pcs), Price (US$/Pc), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Vaxxas Pty Ltd Recent Developments/Updates
Table 80. Vaxxas Pty Ltd Competitive Strengths & Weaknesses
Table 81. Micron Biomedical, Inc. Basic Information, Manufacturing Base and Competitors
Table 82. Micron Biomedical, Inc. Major Business
Table 83. Micron Biomedical, Inc. Vaccine Microarray Patches (VMAPs) Product and Services
Table 84. Micron Biomedical, Inc. Vaccine Microarray Patches (VMAPs) Production (K Pcs), Price (US$/Pc), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Micron Biomedical, Inc. Recent Developments/Updates
Table 86. Micron Biomedical, Inc. Competitive Strengths & Weaknesses
Table 87. QuadMedicine, Inc. Basic Information, Manufacturing Base and Competitors
Table 88. QuadMedicine, Inc. Major Business
Table 89. QuadMedicine, Inc. Vaccine Microarray Patches (VMAPs) Product and Services
Table 90. QuadMedicine, Inc. Vaccine Microarray Patches (VMAPs) Production (K Pcs), Price (US$/Pc), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. QuadMedicine, Inc. Recent Developments/Updates
Table 92. QuadMedicine, Inc. Competitive Strengths & Weaknesses
Table 93. Inventprise, LLC Basic Information, Manufacturing Base and Competitors
Table 94. Inventprise, LLC Major Business
Table 95. Inventprise, LLC Vaccine Microarray Patches (VMAPs) Product and Services
Table 96. Inventprise, LLC Vaccine Microarray Patches (VMAPs) Production (K Pcs), Price (US$/Pc), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. Inventprise, LLC Recent Developments/Updates
Table 98. Inventprise, LLC Competitive Strengths & Weaknesses
Table 99. Kindeva Drug Delivery Basic Information, Manufacturing Base and Competitors
Table 100. Kindeva Drug Delivery Major Business
Table 101. Kindeva Drug Delivery Vaccine Microarray Patches (VMAPs) Product and Services
Table 102. Kindeva Drug Delivery Vaccine Microarray Patches (VMAPs) Production (K Pcs), Price (US$/Pc), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. Kindeva Drug Delivery Recent Developments/Updates
Table 104. Kindeva Drug Delivery Competitive Strengths & Weaknesses
Table 105. LTS Lohmann Therapie-Systeme AG Basic Information, Manufacturing Base and Competitors
Table 106. LTS Lohmann Therapie-Systeme AG Major Business
Table 107. LTS Lohmann Therapie-Systeme AG Vaccine Microarray Patches (VMAPs) Product and Services
Table 108. LTS Lohmann Therapie-Systeme AG Vaccine Microarray Patches (VMAPs) Production (K Pcs), Price (US$/Pc), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. LTS Lohmann Therapie-Systeme AG Recent Developments/Updates
Table 110. LTS Lohmann Therapie-Systeme AG Competitive Strengths & Weaknesses
Table 111. RAPHAS Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 112. RAPHAS Co., Ltd. Major Business
Table 113. RAPHAS Co., Ltd. Vaccine Microarray Patches (VMAPs) Product and Services
Table 114. RAPHAS Co., Ltd. Vaccine Microarray Patches (VMAPs) Production (K Pcs), Price (US$/Pc), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. RAPHAS Co., Ltd. Recent Developments/Updates
Table 116. RAPHAS Co., Ltd. Competitive Strengths & Weaknesses
Table 117. WCC BIOMEDICAL CO., LTD. Basic Information, Manufacturing Base and Competitors
Table 118. WCC BIOMEDICAL CO., LTD. Major Business
Table 119. WCC BIOMEDICAL CO., LTD. Vaccine Microarray Patches (VMAPs) Product and Services
Table 120. WCC BIOMEDICAL CO., LTD. Vaccine Microarray Patches (VMAPs) Production (K Pcs), Price (US$/Pc), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 121. WCC BIOMEDICAL CO., LTD. Recent Developments/Updates
Table 122. WCC BIOMEDICAL CO., LTD. Competitive Strengths & Weaknesses
Table 123. Gylden Pharma Limited Basic Information, Manufacturing Base and Competitors
Table 124. Gylden Pharma Limited Major Business
Table 125. Gylden Pharma Limited Vaccine Microarray Patches (VMAPs) Product and Services
Table 126. Gylden Pharma Limited Vaccine Microarray Patches (VMAPs) Production (K Pcs), Price (US$/Pc), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 127. Gylden Pharma Limited Recent Developments/Updates
Table 128. Gylden Pharma Limited Competitive Strengths & Weaknesses
Table 129. Shenzhen BioQingLam Biotechnology Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 130. Shenzhen BioQingLam Biotechnology Co., Ltd. Major Business
Table 131. Shenzhen BioQingLam Biotechnology Co., Ltd. Vaccine Microarray Patches (VMAPs) Product and Services
Table 132. Shenzhen BioQingLam Biotechnology Co., Ltd. Vaccine Microarray Patches (VMAPs) Production (K Pcs), Price (US$/Pc), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 133. Shenzhen BioQingLam Biotechnology Co., Ltd. Recent Developments/Updates
Table 134. Shenzhen BioQingLam Biotechnology Co., Ltd. Competitive Strengths & Weaknesses
Table 135. CeraVx B.V. Basic Information, Manufacturing Base and Competitors
Table 136. CeraVx B.V. Major Business
Table 137. CeraVx B.V. Vaccine Microarray Patches (VMAPs) Product and Services
Table 138. CeraVx B.V. Vaccine Microarray Patches (VMAPs) Production (K Pcs), Price (US$/Pc), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 139. CeraVx B.V. Recent Developments/Updates
Table 140. CeraVx B.V. Competitive Strengths & Weaknesses
Table 141. Verndari, Inc. Basic Information, Manufacturing Base and Competitors
Table 142. Verndari, Inc. Major Business
Table 143. Verndari, Inc. Vaccine Microarray Patches (VMAPs) Product and Services
Table 144. Verndari, Inc. Vaccine Microarray Patches (VMAPs) Production (K Pcs), Price (US$/Pc), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 145. Verndari, Inc. Recent Developments/Updates
Table 146. Verndari, Inc. Competitive Strengths & Weaknesses
Table 147. MEDRx Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 148. MEDRx Co., Ltd. Major Business
Table 149. MEDRx Co., Ltd. Vaccine Microarray Patches (VMAPs) Product and Services
Table 150. MEDRx Co., Ltd. Vaccine Microarray Patches (VMAPs) Production (K Pcs), Price (US$/Pc), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 151. MEDRx Co., Ltd. Recent Developments/Updates
Table 152. MEDRx Co., Ltd. Competitive Strengths & Weaknesses
Table 153. Advaccine Biopharmaceuticals Suzhou Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 154. Advaccine Biopharmaceuticals Suzhou Co., Ltd. Major Business
Table 155. Advaccine Biopharmaceuticals Suzhou Co., Ltd. Vaccine Microarray Patches (VMAPs) Product and Services
Table 156. Advaccine Biopharmaceuticals Suzhou Co., Ltd. Vaccine Microarray Patches (VMAPs) Production (K Pcs), Price (US$/Pc), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 157. Advaccine Biopharmaceuticals Suzhou Co., Ltd. Recent Developments/Updates
Table 158. Advaccine Biopharmaceuticals Suzhou Co., Ltd. Competitive Strengths & Weaknesses
Table 159. Youwe (Zhuhai) Biotechnology Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 160. Youwe (Zhuhai) Biotechnology Co., Ltd. Major Business
Table 161. Youwe (Zhuhai) Biotechnology Co., Ltd. Vaccine Microarray Patches (VMAPs) Product and Services
Table 162. Youwe (Zhuhai) Biotechnology Co., Ltd. Vaccine Microarray Patches (VMAPs) Production (K Pcs), Price (US$/Pc), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 163. Youwe (Zhuhai) Biotechnology Co., Ltd. Recent Developments/Updates
Table 164. Youwe (Zhuhai) Biotechnology Co., Ltd. Competitive Strengths & Weaknesses
Table 165. CosMED Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 166. CosMED Pharmaceutical Co., Ltd. Major Business
Table 167. CosMED Pharmaceutical Co., Ltd. Vaccine Microarray Patches (VMAPs) Product and Services
Table 168. CosMED Pharmaceutical Co., Ltd. Vaccine Microarray Patches (VMAPs) Production (K Pcs), Price (US$/Pc), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 169. CosMED Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 170. CosMED Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
Table 171. SingleTimeMicroneedles, Inc. Basic Information, Manufacturing Base and Competitors
Table 172. SingleTimeMicroneedles, Inc. Major Business
Table 173. SingleTimeMicroneedles, Inc. Vaccine Microarray Patches (VMAPs) Product and Services
Table 174. SingleTimeMicroneedles, Inc. Vaccine Microarray Patches (VMAPs) Production (K Pcs), Price (US$/Pc), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 175. SingleTimeMicroneedles, Inc. Recent Developments/Updates
Table 176. SingleTimeMicroneedles, Inc. Competitive Strengths & Weaknesses
Table 177. Global Key Players of Vaccine Microarray Patches (VMAPs) Upstream (Raw Materials)
Table 178. Global Vaccine Microarray Patches (VMAPs) Typical Customers
Table 179. Vaccine Microarray Patches (VMAPs) Typical Distributors
Table 1. World Vaccine Microarray Patches (VMAPs) Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Vaccine Microarray Patches (VMAPs) Production Value by Region (2021-2026) & (USD Million)
Table 3. World Vaccine Microarray Patches (VMAPs) Production Value by Region (2027-2032) & (USD Million)
Table 4. World Vaccine Microarray Patches (VMAPs) Production Value Market Share by Region (2021-2026)
Table 5. World Vaccine Microarray Patches (VMAPs) Production Value Market Share by Region (2027-2032)
Table 6. World Vaccine Microarray Patches (VMAPs) Production by Region (2021-2026) & (K Pcs)
Table 7. World Vaccine Microarray Patches (VMAPs) Production by Region (2027-2032) & (K Pcs)
Table 8. World Vaccine Microarray Patches (VMAPs) Production Market Share by Region (2021-2026)
Table 9. World Vaccine Microarray Patches (VMAPs) Production Market Share by Region (2027-2032)
Table 10. World Vaccine Microarray Patches (VMAPs) Average Price by Region (2021-2026) & (US$/Pc)
Table 11. World Vaccine Microarray Patches (VMAPs) Average Price by Region (2027-2032) & (US$/Pc)
Table 12. Vaccine Microarray Patches (VMAPs) Major Market Trends
Table 13. World Vaccine Microarray Patches (VMAPs) Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Pcs)
Table 14. World Vaccine Microarray Patches (VMAPs) Consumption by Region (2021-2026) & (K Pcs)
Table 15. World Vaccine Microarray Patches (VMAPs) Consumption Forecast by Region (2027-2032) & (K Pcs)
Table 16. World Vaccine Microarray Patches (VMAPs) Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Vaccine Microarray Patches (VMAPs) Producers in 2025
Table 18. World Vaccine Microarray Patches (VMAPs) Production by Manufacturer (2021-2026) & (K Pcs)
Table 19. Production Market Share of Key Vaccine Microarray Patches (VMAPs) Producers in 2025
Table 20. World Vaccine Microarray Patches (VMAPs) Average Price by Manufacturer (2021-2026) & (US$/Pc)
Table 21. Global Vaccine Microarray Patches (VMAPs) Company Evaluation Quadrant
Table 22. World Vaccine Microarray Patches (VMAPs) Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Vaccine Microarray Patches (VMAPs) Production Site of Key Manufacturer
Table 24. Vaccine Microarray Patches (VMAPs) Market: Company Product Type Footprint
Table 25. Vaccine Microarray Patches (VMAPs) Market: Company Product Application Footprint
Table 26. Vaccine Microarray Patches (VMAPs) Competitive Factors
Table 27. Vaccine Microarray Patches (VMAPs) New Entrant and Capacity Expansion Plans
Table 28. Vaccine Microarray Patches (VMAPs) Mergers & Acquisitions Activity
Table 29. United States VS China Vaccine Microarray Patches (VMAPs) Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Vaccine Microarray Patches (VMAPs) Production Comparison, (2021 & 2025 & 2032) & (K Pcs)
Table 31. United States VS China Vaccine Microarray Patches (VMAPs) Consumption Comparison, (2021 & 2025 & 2032) & (K Pcs)
Table 32. United States Based Vaccine Microarray Patches (VMAPs) Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Vaccine Microarray Patches (VMAPs) Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Vaccine Microarray Patches (VMAPs) Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Vaccine Microarray Patches (VMAPs) Production (2021-2026) & (K Pcs)
Table 36. United States Based Manufacturers Vaccine Microarray Patches (VMAPs) Production Market Share (2021-2026)
Table 37. China Based Vaccine Microarray Patches (VMAPs) Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Vaccine Microarray Patches (VMAPs) Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Vaccine Microarray Patches (VMAPs) Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Vaccine Microarray Patches (VMAPs) Production, (2021-2026) & (K Pcs)
Table 41. China Based Manufacturers Vaccine Microarray Patches (VMAPs) Production Market Share (2021-2026)
Table 42. Rest of World Based Vaccine Microarray Patches (VMAPs) Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Vaccine Microarray Patches (VMAPs) Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Vaccine Microarray Patches (VMAPs) Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Vaccine Microarray Patches (VMAPs) Production, (2021-2026) & (K Pcs)
Table 46. Rest of World Based Manufacturers Vaccine Microarray Patches (VMAPs) Production Market Share (2021-2026)
Table 47. World Vaccine Microarray Patches (VMAPs) Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Vaccine Microarray Patches (VMAPs) Production by Type (2021-2026) & (K Pcs)
Table 49. World Vaccine Microarray Patches (VMAPs) Production by Type (2027-2032) & (K Pcs)
Table 50. World Vaccine Microarray Patches (VMAPs) Production Value by Type (2021-2026) & (USD Million)
Table 51. World Vaccine Microarray Patches (VMAPs) Production Value by Type (2027-2032) & (USD Million)
Table 52. World Vaccine Microarray Patches (VMAPs) Average Price by Type (2021-2026) & (US$/Pc)
Table 53. World Vaccine Microarray Patches (VMAPs) Average Price by Type (2027-2032) & (US$/Pc)
Table 54. World Vaccine Microarray Patches (VMAPs) Production Value by Microneedle Material, (USD Million), 2021 & 2025 & 2032
Table 55. World Vaccine Microarray Patches (VMAPs) Production by Microneedle Material (2021-2026) & (K Pcs)
Table 56. World Vaccine Microarray Patches (VMAPs) Production by Microneedle Material (2027-2032) & (K Pcs)
Table 57. World Vaccine Microarray Patches (VMAPs) Production Value by Microneedle Material (2021-2026) & (USD Million)
Table 58. World Vaccine Microarray Patches (VMAPs) Production Value by Microneedle Material (2027-2032) & (USD Million)
Table 59. World Vaccine Microarray Patches (VMAPs) Average Price by Microneedle Material (2021-2026) & (US$/Pc)
Table 60. World Vaccine Microarray Patches (VMAPs) Average Price by Microneedle Material (2027-2032) & (US$/Pc)
Table 61. World Vaccine Microarray Patches (VMAPs) Production Value by Form of Use, (USD Million), 2021 & 2025 & 2032
Table 62. World Vaccine Microarray Patches (VMAPs) Production by Form of Use (2021-2026) & (K Pcs)
Table 63. World Vaccine Microarray Patches (VMAPs) Production by Form of Use (2027-2032) & (K Pcs)
Table 64. World Vaccine Microarray Patches (VMAPs) Production Value by Form of Use (2021-2026) & (USD Million)
Table 65. World Vaccine Microarray Patches (VMAPs) Production Value by Form of Use (2027-2032) & (USD Million)
Table 66. World Vaccine Microarray Patches (VMAPs) Average Price by Form of Use (2021-2026) & (US$/Pc)
Table 67. World Vaccine Microarray Patches (VMAPs) Average Price by Form of Use (2027-2032) & (US$/Pc)
Table 68. World Vaccine Microarray Patches (VMAPs) Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World Vaccine Microarray Patches (VMAPs) Production by Application (2021-2026) & (K Pcs)
Table 70. World Vaccine Microarray Patches (VMAPs) Production by Application (2027-2032) & (K Pcs)
Table 71. World Vaccine Microarray Patches (VMAPs) Production Value by Application (2021-2026) & (USD Million)
Table 72. World Vaccine Microarray Patches (VMAPs) Production Value by Application (2027-2032) & (USD Million)
Table 73. World Vaccine Microarray Patches (VMAPs) Average Price by Application (2021-2026) & (US$/Pc)
Table 74. World Vaccine Microarray Patches (VMAPs) Average Price by Application (2027-2032) & (US$/Pc)
Table 75. Vaxxas Pty Ltd Basic Information, Manufacturing Base and Competitors
Table 76. Vaxxas Pty Ltd Major Business
Table 77. Vaxxas Pty Ltd Vaccine Microarray Patches (VMAPs) Product and Services
Table 78. Vaxxas Pty Ltd Vaccine Microarray Patches (VMAPs) Production (K Pcs), Price (US$/Pc), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Vaxxas Pty Ltd Recent Developments/Updates
Table 80. Vaxxas Pty Ltd Competitive Strengths & Weaknesses
Table 81. Micron Biomedical, Inc. Basic Information, Manufacturing Base and Competitors
Table 82. Micron Biomedical, Inc. Major Business
Table 83. Micron Biomedical, Inc. Vaccine Microarray Patches (VMAPs) Product and Services
Table 84. Micron Biomedical, Inc. Vaccine Microarray Patches (VMAPs) Production (K Pcs), Price (US$/Pc), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Micron Biomedical, Inc. Recent Developments/Updates
Table 86. Micron Biomedical, Inc. Competitive Strengths & Weaknesses
Table 87. QuadMedicine, Inc. Basic Information, Manufacturing Base and Competitors
Table 88. QuadMedicine, Inc. Major Business
Table 89. QuadMedicine, Inc. Vaccine Microarray Patches (VMAPs) Product and Services
Table 90. QuadMedicine, Inc. Vaccine Microarray Patches (VMAPs) Production (K Pcs), Price (US$/Pc), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. QuadMedicine, Inc. Recent Developments/Updates
Table 92. QuadMedicine, Inc. Competitive Strengths & Weaknesses
Table 93. Inventprise, LLC Basic Information, Manufacturing Base and Competitors
Table 94. Inventprise, LLC Major Business
Table 95. Inventprise, LLC Vaccine Microarray Patches (VMAPs) Product and Services
Table 96. Inventprise, LLC Vaccine Microarray Patches (VMAPs) Production (K Pcs), Price (US$/Pc), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. Inventprise, LLC Recent Developments/Updates
Table 98. Inventprise, LLC Competitive Strengths & Weaknesses
Table 99. Kindeva Drug Delivery Basic Information, Manufacturing Base and Competitors
Table 100. Kindeva Drug Delivery Major Business
Table 101. Kindeva Drug Delivery Vaccine Microarray Patches (VMAPs) Product and Services
Table 102. Kindeva Drug Delivery Vaccine Microarray Patches (VMAPs) Production (K Pcs), Price (US$/Pc), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. Kindeva Drug Delivery Recent Developments/Updates
Table 104. Kindeva Drug Delivery Competitive Strengths & Weaknesses
Table 105. LTS Lohmann Therapie-Systeme AG Basic Information, Manufacturing Base and Competitors
Table 106. LTS Lohmann Therapie-Systeme AG Major Business
Table 107. LTS Lohmann Therapie-Systeme AG Vaccine Microarray Patches (VMAPs) Product and Services
Table 108. LTS Lohmann Therapie-Systeme AG Vaccine Microarray Patches (VMAPs) Production (K Pcs), Price (US$/Pc), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. LTS Lohmann Therapie-Systeme AG Recent Developments/Updates
Table 110. LTS Lohmann Therapie-Systeme AG Competitive Strengths & Weaknesses
Table 111. RAPHAS Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 112. RAPHAS Co., Ltd. Major Business
Table 113. RAPHAS Co., Ltd. Vaccine Microarray Patches (VMAPs) Product and Services
Table 114. RAPHAS Co., Ltd. Vaccine Microarray Patches (VMAPs) Production (K Pcs), Price (US$/Pc), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. RAPHAS Co., Ltd. Recent Developments/Updates
Table 116. RAPHAS Co., Ltd. Competitive Strengths & Weaknesses
Table 117. WCC BIOMEDICAL CO., LTD. Basic Information, Manufacturing Base and Competitors
Table 118. WCC BIOMEDICAL CO., LTD. Major Business
Table 119. WCC BIOMEDICAL CO., LTD. Vaccine Microarray Patches (VMAPs) Product and Services
Table 120. WCC BIOMEDICAL CO., LTD. Vaccine Microarray Patches (VMAPs) Production (K Pcs), Price (US$/Pc), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 121. WCC BIOMEDICAL CO., LTD. Recent Developments/Updates
Table 122. WCC BIOMEDICAL CO., LTD. Competitive Strengths & Weaknesses
Table 123. Gylden Pharma Limited Basic Information, Manufacturing Base and Competitors
Table 124. Gylden Pharma Limited Major Business
Table 125. Gylden Pharma Limited Vaccine Microarray Patches (VMAPs) Product and Services
Table 126. Gylden Pharma Limited Vaccine Microarray Patches (VMAPs) Production (K Pcs), Price (US$/Pc), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 127. Gylden Pharma Limited Recent Developments/Updates
Table 128. Gylden Pharma Limited Competitive Strengths & Weaknesses
Table 129. Shenzhen BioQingLam Biotechnology Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 130. Shenzhen BioQingLam Biotechnology Co., Ltd. Major Business
Table 131. Shenzhen BioQingLam Biotechnology Co., Ltd. Vaccine Microarray Patches (VMAPs) Product and Services
Table 132. Shenzhen BioQingLam Biotechnology Co., Ltd. Vaccine Microarray Patches (VMAPs) Production (K Pcs), Price (US$/Pc), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 133. Shenzhen BioQingLam Biotechnology Co., Ltd. Recent Developments/Updates
Table 134. Shenzhen BioQingLam Biotechnology Co., Ltd. Competitive Strengths & Weaknesses
Table 135. CeraVx B.V. Basic Information, Manufacturing Base and Competitors
Table 136. CeraVx B.V. Major Business
Table 137. CeraVx B.V. Vaccine Microarray Patches (VMAPs) Product and Services
Table 138. CeraVx B.V. Vaccine Microarray Patches (VMAPs) Production (K Pcs), Price (US$/Pc), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 139. CeraVx B.V. Recent Developments/Updates
Table 140. CeraVx B.V. Competitive Strengths & Weaknesses
Table 141. Verndari, Inc. Basic Information, Manufacturing Base and Competitors
Table 142. Verndari, Inc. Major Business
Table 143. Verndari, Inc. Vaccine Microarray Patches (VMAPs) Product and Services
Table 144. Verndari, Inc. Vaccine Microarray Patches (VMAPs) Production (K Pcs), Price (US$/Pc), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 145. Verndari, Inc. Recent Developments/Updates
Table 146. Verndari, Inc. Competitive Strengths & Weaknesses
Table 147. MEDRx Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 148. MEDRx Co., Ltd. Major Business
Table 149. MEDRx Co., Ltd. Vaccine Microarray Patches (VMAPs) Product and Services
Table 150. MEDRx Co., Ltd. Vaccine Microarray Patches (VMAPs) Production (K Pcs), Price (US$/Pc), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 151. MEDRx Co., Ltd. Recent Developments/Updates
Table 152. MEDRx Co., Ltd. Competitive Strengths & Weaknesses
Table 153. Advaccine Biopharmaceuticals Suzhou Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 154. Advaccine Biopharmaceuticals Suzhou Co., Ltd. Major Business
Table 155. Advaccine Biopharmaceuticals Suzhou Co., Ltd. Vaccine Microarray Patches (VMAPs) Product and Services
Table 156. Advaccine Biopharmaceuticals Suzhou Co., Ltd. Vaccine Microarray Patches (VMAPs) Production (K Pcs), Price (US$/Pc), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 157. Advaccine Biopharmaceuticals Suzhou Co., Ltd. Recent Developments/Updates
Table 158. Advaccine Biopharmaceuticals Suzhou Co., Ltd. Competitive Strengths & Weaknesses
Table 159. Youwe (Zhuhai) Biotechnology Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 160. Youwe (Zhuhai) Biotechnology Co., Ltd. Major Business
Table 161. Youwe (Zhuhai) Biotechnology Co., Ltd. Vaccine Microarray Patches (VMAPs) Product and Services
Table 162. Youwe (Zhuhai) Biotechnology Co., Ltd. Vaccine Microarray Patches (VMAPs) Production (K Pcs), Price (US$/Pc), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 163. Youwe (Zhuhai) Biotechnology Co., Ltd. Recent Developments/Updates
Table 164. Youwe (Zhuhai) Biotechnology Co., Ltd. Competitive Strengths & Weaknesses
Table 165. CosMED Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 166. CosMED Pharmaceutical Co., Ltd. Major Business
Table 167. CosMED Pharmaceutical Co., Ltd. Vaccine Microarray Patches (VMAPs) Product and Services
Table 168. CosMED Pharmaceutical Co., Ltd. Vaccine Microarray Patches (VMAPs) Production (K Pcs), Price (US$/Pc), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 169. CosMED Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 170. CosMED Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
Table 171. SingleTimeMicroneedles, Inc. Basic Information, Manufacturing Base and Competitors
Table 172. SingleTimeMicroneedles, Inc. Major Business
Table 173. SingleTimeMicroneedles, Inc. Vaccine Microarray Patches (VMAPs) Product and Services
Table 174. SingleTimeMicroneedles, Inc. Vaccine Microarray Patches (VMAPs) Production (K Pcs), Price (US$/Pc), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 175. SingleTimeMicroneedles, Inc. Recent Developments/Updates
Table 176. SingleTimeMicroneedles, Inc. Competitive Strengths & Weaknesses
Table 177. Global Key Players of Vaccine Microarray Patches (VMAPs) Upstream (Raw Materials)
Table 178. Global Vaccine Microarray Patches (VMAPs) Typical Customers
Table 179. Vaccine Microarray Patches (VMAPs) Typical Distributors
LIST OF FIGURES
Figure 1. Vaccine Microarray Patches (VMAPs) Picture
Figure 2. World Vaccine Microarray Patches (VMAPs) Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Vaccine Microarray Patches (VMAPs) Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Vaccine Microarray Patches (VMAPs) Production (2021-2032) & (K Pcs)
Figure 5. World Vaccine Microarray Patches (VMAPs) Average Price (2021-2032) & (US$/Pc)
Figure 6. World Vaccine Microarray Patches (VMAPs) Production Value Market Share by Region (2021-2032)
Figure 7. World Vaccine Microarray Patches (VMAPs) Production Market Share by Region (2021-2032)
Figure 8. North America Vaccine Microarray Patches (VMAPs) Production (2021-2032) & (K Pcs)
Figure 9. Europe Vaccine Microarray Patches (VMAPs) Production (2021-2032) & (K Pcs)
Figure 10. China Vaccine Microarray Patches (VMAPs) Production (2021-2032) & (K Pcs)
Figure 11. Japan Vaccine Microarray Patches (VMAPs) Production (2021-2032) & (K Pcs)
Figure 12. Vaccine Microarray Patches (VMAPs) Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Vaccine Microarray Patches (VMAPs) Consumption (2021-2032) & (K Pcs)
Figure 15. World Vaccine Microarray Patches (VMAPs) Consumption Market Share by Region (2021-2032)
Figure 16. United States Vaccine Microarray Patches (VMAPs) Consumption (2021-2032) & (K Pcs)
Figure 17. China Vaccine Microarray Patches (VMAPs) Consumption (2021-2032) & (K Pcs)
Figure 18. Europe Vaccine Microarray Patches (VMAPs) Consumption (2021-2032) & (K Pcs)
Figure 19. Japan Vaccine Microarray Patches (VMAPs) Consumption (2021-2032) & (K Pcs)
Figure 20. South Korea Vaccine Microarray Patches (VMAPs) Consumption (2021-2032) & (K Pcs)
Figure 21. ASEAN Vaccine Microarray Patches (VMAPs) Consumption (2021-2032) & (K Pcs)
Figure 22. India Vaccine Microarray Patches (VMAPs) Consumption (2021-2032) & (K Pcs)
Figure 23. Producer Shipments of Vaccine Microarray Patches (VMAPs) by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 24. Global Four-firm Concentration Ratios (CR4) for Vaccine Microarray Patches (VMAPs) Markets in 2025
Figure 25. Global Four-firm Concentration Ratios (CR8) for Vaccine Microarray Patches (VMAPs) Markets in 2025
Figure 26. United States VS China: Vaccine Microarray Patches (VMAPs) Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: Vaccine Microarray Patches (VMAPs) Production Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Vaccine Microarray Patches (VMAPs) Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States Based Manufacturers Vaccine Microarray Patches (VMAPs) Production Market Share 2025
Figure 30. China Based Manufacturers Vaccine Microarray Patches (VMAPs) Production Market Share 2025
Figure 31. Rest of World Based Manufacturers Vaccine Microarray Patches (VMAPs) Production Market Share 2025
Figure 32. World Vaccine Microarray Patches (VMAPs) Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 33. World Vaccine Microarray Patches (VMAPs) Production Value Market Share by Type in 2025
Figure 34. Dissolving
Figure 35. Non-dissolving
Figure 36. World Vaccine Microarray Patches (VMAPs) Production Market Share by Type (2021-2032)
Figure 37. World Vaccine Microarray Patches (VMAPs) Production Value Market Share by Type (2021-2032)
Figure 38. World Vaccine Microarray Patches (VMAPs) Average Price by Type (2021-2032) & (US$/Pc)
Figure 39. World Vaccine Microarray Patches (VMAPs) Production Value by Microneedle Material, (USD Million), 2021 & 2025 & 2032
Figure 40. World Vaccine Microarray Patches (VMAPs) Production Value Market Share by Microneedle Material in 2025
Figure 41. Hyaluronic Acid
Figure 42. Taurine
Figure 43. Triple-helical Collagen
Figure 44. World Vaccine Microarray Patches (VMAPs) Production Market Share by Microneedle Material (2021-2032)
Figure 45. World Vaccine Microarray Patches (VMAPs) Production Value Market Share by Microneedle Material (2021-2032)
Figure 46. World Vaccine Microarray Patches (VMAPs) Average Price by Microneedle Material (2021-2032) & (US$/Pc)
Figure 47. World Vaccine Microarray Patches (VMAPs) Production Value by Form of Use, (USD Million), 2021 & 2025 & 2032
Figure 48. World Vaccine Microarray Patches (VMAPs) Production Value Market Share by Form of Use in 2025
Figure 49. Patches
Figure 50. Direct Topical
Figure 51. World Vaccine Microarray Patches (VMAPs) Production Market Share by Form of Use (2021-2032)
Figure 52. World Vaccine Microarray Patches (VMAPs) Production Value Market Share by Form of Use (2021-2032)
Figure 53. World Vaccine Microarray Patches (VMAPs) Average Price by Form of Use (2021-2032) & (US$/Pc)
Figure 54. World Vaccine Microarray Patches (VMAPs) Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 55. World Vaccine Microarray Patches (VMAPs) Production Value Market Share by Application in 2025
Figure 56. Routine Childhood Immunization
Figure 57. Adolescent / Pre-adolescent Prevention
Figure 58. Travel / Endemic Exposure / Post-exposure
Figure 59. Respiratory Vaccines with Recurring Demand
Figure 60. Outbreak / Pandemic Preparedness
Figure 61. World Vaccine Microarray Patches (VMAPs) Production Market Share by Application (2021-2032)
Figure 62. World Vaccine Microarray Patches (VMAPs) Production Value Market Share by Application (2021-2032)
Figure 63. World Vaccine Microarray Patches (VMAPs) Average Price by Application (2021-2032) & (US$/Pc)
Figure 64. Vaccine Microarray Patches (VMAPs) Industry Chain
Figure 65. Vaccine Microarray Patches (VMAPs) Procurement Model
Figure 66. Vaccine Microarray Patches (VMAPs) Sales Model
Figure 67. Vaccine Microarray Patches (VMAPs) Sales Channels, Direct Sales, and Distribution
Figure 68. Methodology
Figure 69. Research Process and Data Source
Figure 1. Vaccine Microarray Patches (VMAPs) Picture
Figure 2. World Vaccine Microarray Patches (VMAPs) Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Vaccine Microarray Patches (VMAPs) Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Vaccine Microarray Patches (VMAPs) Production (2021-2032) & (K Pcs)
Figure 5. World Vaccine Microarray Patches (VMAPs) Average Price (2021-2032) & (US$/Pc)
Figure 6. World Vaccine Microarray Patches (VMAPs) Production Value Market Share by Region (2021-2032)
Figure 7. World Vaccine Microarray Patches (VMAPs) Production Market Share by Region (2021-2032)
Figure 8. North America Vaccine Microarray Patches (VMAPs) Production (2021-2032) & (K Pcs)
Figure 9. Europe Vaccine Microarray Patches (VMAPs) Production (2021-2032) & (K Pcs)
Figure 10. China Vaccine Microarray Patches (VMAPs) Production (2021-2032) & (K Pcs)
Figure 11. Japan Vaccine Microarray Patches (VMAPs) Production (2021-2032) & (K Pcs)
Figure 12. Vaccine Microarray Patches (VMAPs) Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Vaccine Microarray Patches (VMAPs) Consumption (2021-2032) & (K Pcs)
Figure 15. World Vaccine Microarray Patches (VMAPs) Consumption Market Share by Region (2021-2032)
Figure 16. United States Vaccine Microarray Patches (VMAPs) Consumption (2021-2032) & (K Pcs)
Figure 17. China Vaccine Microarray Patches (VMAPs) Consumption (2021-2032) & (K Pcs)
Figure 18. Europe Vaccine Microarray Patches (VMAPs) Consumption (2021-2032) & (K Pcs)
Figure 19. Japan Vaccine Microarray Patches (VMAPs) Consumption (2021-2032) & (K Pcs)
Figure 20. South Korea Vaccine Microarray Patches (VMAPs) Consumption (2021-2032) & (K Pcs)
Figure 21. ASEAN Vaccine Microarray Patches (VMAPs) Consumption (2021-2032) & (K Pcs)
Figure 22. India Vaccine Microarray Patches (VMAPs) Consumption (2021-2032) & (K Pcs)
Figure 23. Producer Shipments of Vaccine Microarray Patches (VMAPs) by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 24. Global Four-firm Concentration Ratios (CR4) for Vaccine Microarray Patches (VMAPs) Markets in 2025
Figure 25. Global Four-firm Concentration Ratios (CR8) for Vaccine Microarray Patches (VMAPs) Markets in 2025
Figure 26. United States VS China: Vaccine Microarray Patches (VMAPs) Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: Vaccine Microarray Patches (VMAPs) Production Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Vaccine Microarray Patches (VMAPs) Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States Based Manufacturers Vaccine Microarray Patches (VMAPs) Production Market Share 2025
Figure 30. China Based Manufacturers Vaccine Microarray Patches (VMAPs) Production Market Share 2025
Figure 31. Rest of World Based Manufacturers Vaccine Microarray Patches (VMAPs) Production Market Share 2025
Figure 32. World Vaccine Microarray Patches (VMAPs) Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 33. World Vaccine Microarray Patches (VMAPs) Production Value Market Share by Type in 2025
Figure 34. Dissolving
Figure 35. Non-dissolving
Figure 36. World Vaccine Microarray Patches (VMAPs) Production Market Share by Type (2021-2032)
Figure 37. World Vaccine Microarray Patches (VMAPs) Production Value Market Share by Type (2021-2032)
Figure 38. World Vaccine Microarray Patches (VMAPs) Average Price by Type (2021-2032) & (US$/Pc)
Figure 39. World Vaccine Microarray Patches (VMAPs) Production Value by Microneedle Material, (USD Million), 2021 & 2025 & 2032
Figure 40. World Vaccine Microarray Patches (VMAPs) Production Value Market Share by Microneedle Material in 2025
Figure 41. Hyaluronic Acid
Figure 42. Taurine
Figure 43. Triple-helical Collagen
Figure 44. World Vaccine Microarray Patches (VMAPs) Production Market Share by Microneedle Material (2021-2032)
Figure 45. World Vaccine Microarray Patches (VMAPs) Production Value Market Share by Microneedle Material (2021-2032)
Figure 46. World Vaccine Microarray Patches (VMAPs) Average Price by Microneedle Material (2021-2032) & (US$/Pc)
Figure 47. World Vaccine Microarray Patches (VMAPs) Production Value by Form of Use, (USD Million), 2021 & 2025 & 2032
Figure 48. World Vaccine Microarray Patches (VMAPs) Production Value Market Share by Form of Use in 2025
Figure 49. Patches
Figure 50. Direct Topical
Figure 51. World Vaccine Microarray Patches (VMAPs) Production Market Share by Form of Use (2021-2032)
Figure 52. World Vaccine Microarray Patches (VMAPs) Production Value Market Share by Form of Use (2021-2032)
Figure 53. World Vaccine Microarray Patches (VMAPs) Average Price by Form of Use (2021-2032) & (US$/Pc)
Figure 54. World Vaccine Microarray Patches (VMAPs) Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 55. World Vaccine Microarray Patches (VMAPs) Production Value Market Share by Application in 2025
Figure 56. Routine Childhood Immunization
Figure 57. Adolescent / Pre-adolescent Prevention
Figure 58. Travel / Endemic Exposure / Post-exposure
Figure 59. Respiratory Vaccines with Recurring Demand
Figure 60. Outbreak / Pandemic Preparedness
Figure 61. World Vaccine Microarray Patches (VMAPs) Production Market Share by Application (2021-2032)
Figure 62. World Vaccine Microarray Patches (VMAPs) Production Value Market Share by Application (2021-2032)
Figure 63. World Vaccine Microarray Patches (VMAPs) Average Price by Application (2021-2032) & (US$/Pc)
Figure 64. Vaccine Microarray Patches (VMAPs) Industry Chain
Figure 65. Vaccine Microarray Patches (VMAPs) Procurement Model
Figure 66. Vaccine Microarray Patches (VMAPs) Sales Model
Figure 67. Vaccine Microarray Patches (VMAPs) Sales Channels, Direct Sales, and Distribution
Figure 68. Methodology
Figure 69. Research Process and Data Source
